Spinal Muscular Atrophy Natural History Study
Participants of all ages are being recruited to participate in a research study to further characterize the disease process of spinal muscular atrophy (SMA) and identify potential surrogate outcome measures for clinical trials.
For more information or to enroll in this study, please contact Sharon Chelnick at (614) 293-4973 or by e-mail at email@example.com.
Spinal Muscular Atrophy Medication Study
We are currently enrolling ambulatory adults with SMA for a research study to determine if an FDA approved drug called valproic acid will increase muscle strength and function and improve general quality of life.
You may be eligible to participate if you are between 18 and 60 years of age and are able to walk 30 feet without assistance. Participants will receive valproic acid for six months and placebo for six months.
For more information, please contact Sharon Chelnick at (614) 293-4973 or by e-mail at firstname.lastname@example.org.
Multifocal Motor Neuropathy Study
Participants are being recruited to participate in a research study to test the safety, tolerability and effectiveness of Immune Globulin Intravenous (IGIV) therapy to treat Multifocal Motor Neuropathy. Participants must be on a stable dose of IGIV for at least 3 months prior to enrollment.
For more information, please contact Amy Bartlett at (614) 366-9050 or by e-mail at email@example.com.